Sarepta Therapeutics (SRPT) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.27% |
| Dec 31, 2025 | -15.48% |
| Sep 30, 2025 | -2.96% |
| Jun 30, 2025 | 7.46% |
| Mar 31, 2025 | 7.47% |
| Dec 31, 2024 | 21.40% |
| Sep 30, 2024 | 15.76% |
| Jun 30, 2024 | 9.55% |
| Mar 31, 2024 | 5.38% |
| Dec 31, 2023 | 4.35% |
| Sep 30, 2023 | -1.47% |
| Jun 30, 2023 | 4.31% |
| Mar 31, 2023 | 0.12% |
| Dec 31, 2022 | -0.62% |
| Sep 30, 2022 | 18.55% |
| Jun 30, 2022 | 8.62% |
| Mar 31, 2022 | 10.52% |
| Dec 31, 2021 | 5.47% |
| Sep 30, 2021 | -4.26% |
| Jun 30, 2021 | -4.30% |
| Mar 31, 2021 | -6.18% |
| Dec 31, 2020 | 63.74% |
| Sep 30, 2020 | 63.33% |
| Jun 30, 2020 | 64.96% |
| Mar 31, 2020 | 50.08% |
| Dec 31, 2019 | 11.01% |
| Sep 30, 2019 | 43.92% |
| Jun 30, 2019 | 40.14% |
| Mar 31, 2019 | 51.04% |
| Dec 31, 2018 | 25.54% |
| Sep 30, 2018 | 47.81% |
| Jun 30, 2018 | 177.06% |
| Mar 31, 2018 | 154.19% |
| Dec 31, 2017 | 208.41% |
| Sep 30, 2017 | 64.22% |
| Jun 30, 2017 | 120.58% |
| Mar 31, 2017 | 139.75% |
| Dec 31, 2016 | 54.91% |
| Sep 30, 2016 | 163.77% |
| Jun 30, 2016 | -11.93% |
| Mar 31, 2016 | -12.09% |
| Dec 31, 2015 | -7.20% |
| Sep 30, 2015 | -42.09% |
| Jun 30, 2015 | -31.31% |
| Mar 31, 2015 | -11.87% |
| Dec 31, 2014 | 1.19% |
| Sep 30, 2014 | 4.79% |
| Jun 30, 2014 | 83.69% |
| Mar 31, 2014 | 42.44% |
| Dec 31, 2013 | 42.23% |
| Mar 31, 2013 | 314.47% |
| Dec 31, 2012 | 277.05% |
| Dec 31, 2011 | 18.25% |